This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Transgenic Inc.. Active years: 2010.
Company Filing History:
Years Active: 2010
Title: Yusei Nagase: Innovator in Monoclonal Antibody Development
Introduction
Yusei Nagase is a prominent inventor based in Hyogo, Japan. He has made significant contributions to the field of immunology through his innovative work on monoclonal antibodies. His research focuses on developing specific antibodies that can enhance the accuracy of immunoreaction systems.
Latest Patents
Yusei Nagase holds 1 patent related to an anti-diacetylspermine specific monoclonal antibody. This invention provides a unique solution for measuring diacetylspermine levels in samples. The immunoreaction system he developed includes a sample diacetylspermine or sample N-acetylspermidine, which inhibits the immunoreaction. The specific measuring condition established by Nagase ensures that the 50% inhibition activity against the immunoreaction by diacetylspermine is at least 1,000 times greater than that of N-acetylspermidine.
Career Highlights
Yusei Nagase is currently associated with Transgenic Inc., where he continues to advance his research in monoclonal antibodies. His work has garnered attention for its potential applications in medical diagnostics and therapeutic interventions.
Collaborations
Nagase collaborates with notable colleagues, including Shingo Shinagawa and Mika Ito. Their combined expertise contributes to the innovative environment at Transgenic Inc.
Conclusion
Yusei Nagase's contributions to the field of immunology through his patented monoclonal antibody demonstrate his commitment to advancing medical science. His work has the potential to significantly impact diagnostic and therapeutic practices in healthcare.